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Abstract
The influenza virus polymerase is formed by the PB1, PB2 and PA subunits and is required for virus transcription and
replication in the nucleus of infected cells. As PB2 is a relevant host-range determinant we expressed a TAP-tagged PB2 in
human cells and isolated intracellular complexes. Alpha-importin was identified as a PB2-associated factor by proteomic
analyses. To study the relevance of this interaction for virus replication we mutated the PB2 NLS and analysed the
phenotype of mutant subunits, polymerase complexes and RNPs. While mutant PB2 proteins showed reduced nuclear
accumulation, they formed polymerase complexes normally when co expressed with PB1 and PA. However, mutant RNPs
generated with a viral CAT replicon showed up to hundred-fold reduced CAT accumulation. Rescue of nuclear localisation of
mutant PB2 by insertion of an additional SV40 TAg-derived NLS did not revert the mutant phenotype of RNPs. Furthermore,
determination of recombinant RNP accumulation in vivo indicated that PB2 NLS mutations drastically reduced virus RNA
replication. These results indicate that, above and beyond its role in nuclear accumulation, PB2 interaction with a-importins
is required for virus RNA replication. To ascertain whether PB2-a-importin binding could contribute to the adaptation of
H5N1 avian viruses to man, their association in vivo was determined. Human alpha importin isoforms associated efficiently
to PB2 protein of an H3N2 human virus but bound to diminished and variable extents to PB2 from H5N1 avian or human
strains, suggesting that the function of alpha importin during RNA replication is important for the adaptation of avian
viruses to the human host.
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Introduction
Transcription and replication of influenza A virus is carried out in
the nucleus of the infected cells by each of the eight ribonucleo-
protein particles (RNPs) that constitute their genome (reviewed in
[1–3]). Each RNP contains one single-stranded RNA segment
encapsidated by binding to nucleoprotein (NP) monomers and the
polymerase complex [4], a heterotrimer containing the PB1, PB2
and PA subunits. Within the RNP, the viral RNA polymerase is the
enzyme responsible for transcription and replication. The PB1
subunit is responsible for the polymerase and endonuclease
activities, PB2 binds the cap structure of cellular pre-mRNAs and
PA is a phosphoprotein with protease activity involved in RNA
replication (reviewed in [1,2]). These subunits form a tight and
stable complex whose low-resolution structure has been determined
by electron microscopy and image processing [5,6]. The PB1
subunit is the core of the complex and interacts with both PB2 and
PA, whereas no interaction between PB2 and PA proteins has been
described. Each polymerase subunit can be translocated to the
nucleus as they contain nuclear localisation signals (NLSs) [7–9] and
the precise structure of the PB2 NLS has recently been determined
by co-crystal formation with importin a5 [10]. However, the
intracellular site and the pathway for complex formation are not
clear at present. It has been proposed that the PB1-PA dimer would
be formed in the cytoplasm and transported to the nucleus whereas
PB2 would be transported independently [11,12]. The PB1-PA
dimer and PB2 would then form the heterotrimer in the nucleus, as
supported by in vitro assembly reactions [13]. Alternative proposals
are based on the formation of Hsp90 complexes with PB1 and PB2
and suggest the formation of PB1-PB2 and PB1-PA dimers and their
co-transport to the nucleus [14,15].
In this report we have studied the role in the infection of
influenza PB2 subunit by proteomic analysis of intracellular
complexes containing PB2 and mutation of the recently described
NLS [10]. We found a-importins as PB2-associated host factors
and showed that they bind efficiently to PB2 derived from a
human virus but associate to a diminished and isoform-specific
way to PB2 from H5N1 avian viruses. Although polymerase
complex formation was not affected by mutation of PB2 NLS,
RNP activity was essentially abolished. Restoring nuclear import
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by ectopic addition of a SV40 TAg NLS did not rescue the RNP
biological activity, suggesting that PB2 interaction with a-importin
is required for the biological activity of influenza polymerase, in
addition to its role in protein transport. Furthermore, mutation of
PB2 NLS abrogated the capacity of recombinant RNPs to
accumulate in vivo, indicating that the interaction of importin a
with the natural NLS in PB2 is necessary for viral RNA
replication.
Results
Importins a associate in vivo with the influenza
polymerase PB2 subunit
To determine the human host factors that associate in vivo with
the PB2 subunit of the influenza RNA polymerase we expressed a
TAP-tagged version of the protein (Fig. 1A) by transfection of
human cells and purified the intracellular complexes formed in vivo
by tandem affinity chromatography as described [16]. As a control,
untagged PB2 was expressed and purified in parallel. MS-MS
analysis of the purified complexes identified the presence of
importin a5, in addition to the purified PB2 subunit (Tables S1
and S2). To verify biochemically these results, the purified PB2-
containing complexes were analysed by Western-blot with a-
importin-specific antibodies. The results presented in Fig. 1B, C
show the co-purification of importin a5 with PB2 and the in vivo
association of importins a1, a5 and a7 with PB2. These results are
consistent with the co-crystallisation of importin a5 with the NLS-
containing C-terminal domain of PB2 protein [10] and the co-
localisation of importin a1 with PB2 in influenza virus-infected cells
[17]. The accepted mechanism for nuclear import implies that
importin-cargo interaction is transient and is eliminated once the
nuclear envelope barrier is overcome. The fact that it is possible to
isolate stable intracellular complexes of PB2 and importin a (Fig. 1D)
would suggest that such interaction might have a biological role
other than the expected for PB2 nuclear import.
Mutations in the NLS of PB2 do not alter polymerase
complex formation but abolish the activity of viral RNPs
To study the possible functions of PB2-importin a interactions
we generated PB2 mutants altered in the bipartite NLS. Mutants
in NLS-1 (R737Q –mutant 737- or K738Q –mutant 738-), in
NLS-2 (K752N+R755Q –mutant KNRQ-) or in both regions
(K738Q+K752N+R755Q -mutant 8/K-) were generated. These
mutations were described previously on the basis of the co-crystal
structure of PB2 NLS domain bound to alpha importin and
progressively decreased the interaction of PB2 with the importin
[10]. In addition, a deletion mutant in which the complete NLS
was eliminated was also produced –mutant DNLS- (Fig. 2A). After
verifying that all mutant PB2 proteins were expressed correctly
(Fig. S1), their nuclear import in HeLa cells was tested by indirect
immunofluorescence using PB2-specific antibodies. Representative
images are presented in Fig. 2B and a summary of the phenotypes
is shown in Fig. 2C. The results are consistent with those reported
for the mutant C-terminal domain of PB2 fused to GFP [10] and
indicate that nuclear accumulation of untagged PB2 protein is
slightly affected by single-point mutations in NLS1 and more
inhibited by a double mutation in NLS2. Thus, only slight PB2
cytoplasmic staining was apparent in the 737 or 738 mutants,
while mutants KNRQ and 8/K had similar concentrations of PB2
in the nucleus and the cytoplasm. Even mutant DNLS showed
some nuclear staining. Similar phenotypes were observed in
HEK293T cells (Fig. S2). The biological activity of these mutants
was first tested in a RNP replication system using a CAT gene-
containing viral replicon. Cells were transfected with plasmids
encoding each of the polymerase subunits, the NP and the
recombinant replicon. Either wt or mutant PB2-encoding plasmids
were used, while PB2 plasmid was omitted as a negative control.
Figure 1. Purification of PB2-containing intracellular complex-
es. (A) Diagram of the PB2TAP recombinant protein. The structure of
the C-terminal TAP tag is shown, with the calmodulin-binding domain
(CBD), the TEV cleavage site (TEV) and the IgG-binding domain (ProtA).
Also marked are the cap-binding domain (CapBS) [41], and the NLS [10].
(B) Analysis of the purification of recombinant PB2TAP or control PB2
protein by Western-blot. Also shown is the co-purification of a-importin
using anti-importin antibodies. The purification fractions analysed were
as follows: Input extract (IN), material not bound to IgG (NBI), material
bound to IgG (BI), material cleaved with TEV protease (CT), material not
eluted from IgG (NE), material not bound to calmodulin-agarose (NBC),
elutions from calmodulin-agarose (E1–E7) and material not eluted from
calmodulin-agarose (FE). The material used for each purification is
indicated on the left (Sample), whereas the position of the Western-blot
signals (WB) is shown to the right. (C) Identification of a-importin
isoforms associated to PB2. The proteins eluted with TEV protease from
the IgG-Sepharose column were analysed by Western-blot with
antibodies specific for various forms of a-importin. The antibodies
used are indicated to the left whereas the position of the Western-blot
signals is shown to the right. (D) Composition of polymerase subunits
PB2-associated proteins. Complexes containing PB2 were purified from
PB2-TAP- (PB2-TAP) or PB2-transfected cells (PB2), using the TAP
approach. Aliquots of the samples after two affinity chromatography
steps were analysed by polyacrylamide gel electrophoresis and silver
staining. The position of molecular weight markers is indicated to the
left. Only the relevant sections of the gel are shown.
doi:10.1371/journal.pone.0003904.g001
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The CAT protein accumulation was used as a measure of the
combined replication-transcription activity of each recombinant
RNP. The results obtained are presented in Fig. 2D and show that
the NLS mutations in PB2 lead to a much stronger phenotype
than that expected from the intracellular localisation of the
protein. Thus, mutants 737 and 738, which show a localisation
hardly distinguishable from wt PB2 (Fig. 2B), led to RNPs 2–4
times less active than wt RNPs. On the other hand, mutants
KNRQ and 8/K, which still show considerable accumulation of
PB2 in the nucleus (Fig. 2B), gave rise to RNPs 10–100 times less
active than wt. In addition, mutant DNLS, which was not
completely excluded from the nucleus, was completely inactive.
These results indicated that there is a correlation between the
progressive reduction in mutant PB2 domain interaction with
importin alpha [10] and a decrease in the activity of the mutant
RNPs. However, the much stronger activity phenotype suggested
that the defect in PB2 intracellular localisation is not the only
cause for the reduction in mutant RNP activity and led us to test
other alternatives. A naı¨ve explanation would be that the
polymerase complex is not formed. Hence, we tested this
possibility by cotransfection of plasmids expressing PB1, His-
TEVPA and either wt or mutant PB2, and pull-down with Ni-
NTA-agarose. Complex formation was ascertained by Western-
blot with anti-PB2 antibodies and is shown in Fig. 3. No significant
differences were observed in the capacity of mutant or wt PB2
proteins to produce polymerase complexes.
Insertion of an ectopic NLS does not rescue the activity
of RNPs generated with NLS PB2 mutants
To distinguish whether the interaction of a-importins to the C-
terminal NLS of PB2 is only important for its nuclear
accumulation or it rather plays additional roles in the activity of
the virus RNPs we tried to rescue the nuclear localisation of the
PB2 mutants by the ectopic insertion of an alternative NLS. Thus,
a SV40 TAg NLS was inserted at the C-terminus of either wt or
each of the most affected PB2 mutants, KNRQ, 8/K and DNLS
(see Fig. 4A for a diagram), and the localisations of the chimeric
proteins were tested by indirect immunofluorescence of transfected
cells. As expected, nuclear localisation was maintained in the wt
protein and was rescued for the KNRQ and 8/K mutant proteins
containing a TAg NLS (Fig. 4B, C). As rescue of DNLS mutant
was not complete, its phenotype was not analysed further. After
verification that the TAg NLS-containing PB2 proteins formed
heterotrimeric polymerase complexes efficiently (Fig. 3), we tested
the intracellular localisation of wt or mutant PB2 proteins in cells
co-expressing the other subunits of the polymerase. Cultures of
HEK293T cells were cotransfected with plasmids expressing PB1,
PA and either wt or the mutant PB2 proteins with stronger
phenotypes (KNRQ SV or 8/K SV). As it has been shown that
nuclear transport of PB1-PA and PB2 proteins are independent
[11,13], the cells were analysed by immunofluorescence by
double-staining with antibodies specific for PB1 and PB2.
Representative images are presented in Fig. 5 and the quantitation
of the data appears in Fig. 6A. These results show that both wt and
Figure 2. Phenotype of PB2 mutants with altered NLS. (A)
Sequence of the PB2 NLS located close to the C-terminus. The position
of the two regions of the bipartite NLS (NLS-1 and NLS-2) is indicated, as
well as the mutations present in mutants 737, 738, KNRQ, 8/K and DNLS.
(B) Representative intracellular localisations of wt and mutant PB2
proteins. Central optical sections are presented of HeLa cells mock-
transfected (MOCK), transfected with wt PB2 (WT) or with each of the
mutant PB2 proteins. Nuclei were stained with DAPI (blue) and PB2 was
stained with anti-PB2 monoclonal antibody and goat anti-mouse IgG
coupled with Alexa 488 (green). (C) Quantitative estimation of the
localisation of wt or mutant PB2 proteins. Around 100 individual cells
were scored as: N, exclusively nuclear; N.C, nuclei more stained than
the cytoplasm; NC, equal nuclear and cytoplasmic staining or C,
exclusively cytoplasmic staining. (D) Biological activity of recombinant
RNPs with mutated PB2 proteins. Cultures of HEK293T cells were co-
transfected with plasmids expressing PB1, PA, NP and either wt or
mutant PB2, as well as a plasmid encoding CAT gene in negative
polarity, flanked by the non-translated regions of influenza NS segment.
Plasmid expressing PB2 was omitted as a negative control. At 20 hours
post-transfection total cell extracts were prepared and CAT protein was
determined by ELISA. The averages and standard deviations of 3–9
independent experiments are shown.
doi:10.1371/journal.pone.0003904.g002
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mutant PB2 proteins containing a TAg NLS are localised to the
nucleus in cells positive for PB1 staining. Therefore, neither the
NLS point mutations nor the insertion of the TAg NLS altered
significantly the folding of PB2, as it could correctly form
polymerase complex (Fig. 3) and be transported to the nucleus
(Figs 5 and 6A).
The activity of each of these rescued mutant RNPs was again
tested in the CAT minireplicon assay as described above and the
results are presented in Fig. 6B. The insertion of a TAg NLS
downstream of wt PB2 led to a 2–3-fold decrease in the
accumulation of CAT protein and similar reductions were
observed for the KNRQ and 8/K mutants (Fig. 6B). No rescue
of CAT expression was observed for RNPs with KNRQ or 8/K
mutations in PB2 by insertion of an additional NLS, in spite of an
almost complete nuclear localisation of the mutant PB2 proteins.
Therefore, we can conclude that the lack of nuclear localisation of
PB2 mutants is not the main cause for the lack of RNP activity.
Rather, the NLS mutations must affect a step downstream in the
infection cycle, probably during RNA replication or transcription.
Mutation of the PB2 NLS affects viral RNA replication
To determine which step in viral replication requires the
interaction of virus polymerase with importin a, we reconstituted
in vivo RNPs using as replicon a 248 nt long negative polarity
RNA derived from viral RNA 8 [18]. Such RNPs accumulate
efficiently in vivo and can be purified biochemically [4,5]. The cell
cultures were transfected with plasmids expressing PA, NP and
either wt or mutant PB2 proteins containing an additional TAg
NLS. To allow RNP purification, a TAP-tagged PB1 protein was
coexpressed [5,16]; alternatively, untagged PB1 was used as a
control. In this way, the progeny RNPs produced in vivo could be
bound to IgG-Sepharose and eluted specifically by digestion with
TEV protease [16]. In this assay, the amount of purified
recombinant RNPs is a measure of their replication in vivo, as
any polymerase null mutation abolish the generation of RNPs
[19,20]. The accumulation of viral RNPs was measured by
Western-blot with antibodies specific for NP. The results are
presented in Fig. 7A, B and show clearly that the accumulation of
RNPs in vivo was almost abolished when the KNRQ or 8/K
mutations were introduced in PB2 protein. These results were
confirmed by determination of the transcriptional activity of the
purified RNPs. The average and standard deviation of three
independent purification experiments are presented in Fig. 7C,
again showing that essentially no in vivo accumulation of RNPs
occurred when mutations KNRQ or 8/K were introduced in PB2.
Strain-dependent interaction of human a-importins to
the PB2 subunits of influenza viruses
The PB2 protein is one of the most relevant viral determinants
for avian virus adaptation to human cells [21,22] and adaptation
of an avian virus to mice involves alteration of PB2 interaction
with a-importins [17]. These facts, together with the importance
of the interaction of PB2 with a-importins for viral replication
prompted us to test whether PB2 proteins derived from viruses of
Figure 3. Polymerase complex formation of wt and mutant PB2 proteins. Cultures of HEK293T cells were co-transfected with plasmids
expressing PB1, HisTEVPA or PA as a control, and either wt or mutant PB2. PB2 was omitted as a control. Total cell extracts were prepared and
analysed by pull-down with 2+Ni-NTA-agarose and Western-blot using anti-PB2 and anti-PA monoclonal antibodies. (A). Controls for the pull-down
experiment. (B). Analysis of PB2 mutants. IN: Input extract. NB: Not bound to the resin. E: Eluted fractions. SV denotes that an additional NLS derived
from SV40 TAg has been inserted. An extract obtained from influenza virus-infected cells was used as mobility marker (Flu).
doi:10.1371/journal.pone.0003904.g003
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different phylogenetic origins would show differential capacities for
an stable association to human a-importins. Thus, the PB2 coding
regions of A/Goose/Guandong/1/97 (H5N1), an avian strain,
and those from A/Vietnam/1203/04 (H5N1) and A/Thailand/
Kan1/04 (H5N1), two viruses isolated from sporadic avian
influenza cases in humans, were TAP-tagged, expressed in human
cells and used to pull-down a-importins. As a positive control, A/
Victoria/3/75 (H3N2) PB2 was used, as described in Fig. 1C,
whereas untagged PB2 was employed as a negative control. The
results are presented in Fig. 8. A much reduced association was
observed for PB2 proteins of avian H5N1 viruses, both isolated
from avian species or from sporadic cases in man. In addition, the
interaction is clearly dependent on the a-importin isoform. Thus,
a5-importin and a7-importin interaction to PB2 from H5N1
viruses was negligible, whereas association of a1-importin was only
partly diminished as compared with the signal for the PB2 from a
human H3N2 virus. These results indicate that the stable
interaction of PB2 with a-importins is host-dependent. Further-
more, the reduced co-purification of a-importins, particularly a5-
and a7-importins, with PB2 proteins from H5N1 viruses correlate
with their reduced replication capacity in human cells [23],
suggesting that this interaction might play a role in the adaptation
of avian H5N1 viruses to replication in the human host.
Discussion
The PB2 subunit of the influenza polymerase is an essential
element for virus RNA transcription and replication [20,24,25]
Figure 4. Intracellular localisation of mutated PB2 proteins containing an ectopic NLS. (A) Diagram showing the structure of PB2 protein
containing a SV40 TAg NLS at its C-terminus. (B) Representative phenotypes of the intracellular localisation of wt and mutant PB2 proteins. Cultures of
HEK293T cells were transfected with plasmids expressing either wt or mutant PB2 proteins containing an additional NLS signal at the protein C-
terminus. Central optical sections are presented of mock-transfected (MOCK), transfected with wt PB2 (WT) or with each of the mutant PB2 proteins.
The phenotype of the DNLS mutant lacking the SV40 TAg NLS is also shown. Nuclei were stained with DAPI (blue) and PB2 was stained with anti-PB2
monoclonal antibody and goat anti-mouse IgG coupled with Alexa 488 (green) (C) Quantitative estimation of the localisation of wt or mutant PB2
proteins was performed as indicated in Fig. 2C.
doi:10.1371/journal.pone.0003904.g004
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and, in addition, it has been described as a relevant viral gene in
the definition of host-range [21–23,26–28]. Hence we set out to
purify intracellular complexes containing PB2 protein using the
TAP purification approach [29], as performed for the polymerase
complex [16]. It was not surprising to identify a-importin among
the proteins associated to PB2 (Fig. 1), since a NLS has been
identified at its C-terminus [7] and a PB2 C-terminal domain
could be co-crystallised with a-importin [10]. However, the
stability of the interaction in vivo was unexpected (Fig. 1D) and
hence the relevance of the PB2 interaction to a-importins for
influenza virus infection was analysed by mutation. In agreement
with previous data reported for NLS domain-a-importin interac-
tion, mutation of the NLS resulted in defective nuclear import of
mutant PB2 proteins, although none of the mutations led to
exclusion of the protein from the nucleus (Fig. 2B) and their
capacity to form polymerase complexes in vivo was not altered
(Fig. 3). In spite of proper formation of polymerase complexes, the
activity of RNPs including NLS mutations in PB2 was progres-
sively reduced, in parallel to the decrease in their ability to interact
with a-importin [10], as reflected in the activity of a CAT replicon
in vivo (Fig. 2D). Altogether, the results obtained suggested that
the interaction of a-importins with the C-terminal NLS in PB2
might serve an additional role, distinct from its normal function for
nuclear import, during influenza virus infection. A usual approach
to test the relevance of a host factor in a virus infection is to down-
regulate its expression by gene silencing and analyse the
consequences for the replication of the virus. Such an approach
would not be useful here, as down-regulation of a-importins would
reduce nuclear accumulation of PB2 (and other cellular and viral
proteins) and hence lead to indirect, non-informative phenotypes.
As an alternative, we rescued the nuclear localisation of NLS PB2
mutants by insertion of an additional NLS derived from SV40
TAg (Figs. 4, 5) and asked whether the rescued mutants would lead
to the recovery of the biological activity of the RNPs in vivo. The
results showed clearly that this was not the case (Fig. 6B),
indicating that indirectly driven nuclear localisation is not
sufficient for RNP activity and suggesting that correct binding of
a-importin to the bona-fide PB2 NLS is required. The correlation
between (i) the import phenotype of the various mutants
generated, (ii) their ability to interact in vitro with a-importin
[10] and (iii) the reduced activity of the mutant-containing RNPs,
makes it very unlikely that the functional defect described here is
unrelated to the alterations in PB2-a-importin interaction. It could
be argued that insertion of the SV40 TAg NLS itself impairs the
activity of the RNPs but this is also unlikely since (i) it only
diminishes the activity of wt RNPs by twofold (Fig. 6B) and (ii)
insertion of any tags at PB2 C-terminus (His, TAP, GFP) did not
alter the activity of RNPs [5,11].
As PB2 protein is involved in the cap-RNA recognition required
for cap-snatching, it might be hypothesized that interaction with
a-importin is important for viral transcription initiation. However,
purified viral RNPs, either derived from virions or isolated from a
recombinant system, are capable of efficient in vitro transcription
using capped mRNA as a cap donor [5] (R. Coloma, unpublished
results), suggesting that a-importin is not an essential cofactor for
viral transcription. Indeed, the experiments reported here revealed
that alteration of PB2 NLS abolishes virus RNP accumulation in
vivo (Fig. 7). These results are consistent with the transient
accumulation of a-importin in the nucleus of infected cells [17]
and are easier interpreted by proposing that a-importin acts as a
cofactor for virus RNA replication, although we can not exclude
that it also plays a role during transcription of progeny RNPs. At
least two alternative models can be put forward to explain the
requirement of a-importin: either bona fide interaction of PB2 with
a-importin is necessary for the proper folding of an active viral
polymerase complex or it is needed for RNP replication itself.
Further experimentation will be required to distinguish between
both possibilities.
Our results should also be put in the perspective of the
adaptation of avian influenza viruses to mammalian hosts, in
particular to man. As indicated above, the PB2 gene is a major
player in the ability of avian polymerase complexes to replicate in
mammalian hosts [21–23,27,28] (reviewed in [30]). A series of
mutation signatures in PB2 have been identified that accompany
avian virus adaptation [26], some of which are located close to the
NLS-containing domain in the primary sequence (for example
A674T, K702R) (Fig. 8B). Other host-range mutations lay far
apart in the sequence of PB2 [26] but it is possible that some of
them are spatially close to the a-importin binding site and might
alter the interaction with a-importin, as suggested from the co-
crystal structure determined recently [10]. Moreover, it has been
recently shown that mutation D701N stimulates binding of PB2 to
a-importin in human but not in avian cells [17]. The differential
interaction of PB2 proteins derived from viruses of avian and
human origin with human a-importins (Fig. 8A), is spite of having
Figure 5. Intracellular localisation of wt and mutant PB2
proteins in cells co-expressing the polymerase subunits.
Cultures of HEK293T cells were co-transfected with plasmids expressing
PB1, PA and either wt or mutant PB2 containing an additional TAg NLS.
The cultures were fixed and analysed by double immunofluorescence
using antibodies specific for PB1 and PB2 proteins. The signals for
nuclear staining (DAPI –blue-), PB1 protein (PB1 –red-), PB2 protein (PB2
–green-) and the merge of PB1 and PB2 signals are shown for mock-
transfected cells (Mock), cells expressing PB1 and PA (No PB2), cells
expressing wt polymerase (WT), cells expressing polymerase with PB2-
SV protein (WT SV) or cells expressing mutant polymerase containing
each of the PB2 mutants with additional TAg NLS (KNRQ SV and 8/K SV).
doi:10.1371/journal.pone.0003904.g005
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no differences in the C-terminal NLS, suggests that other regions
in the protein might be responsible for the stable association
observed. This would be in agreement with the observation that,
even in mutant 8/K which contains three mutations affecting both
sections of the C-terminal NLS, partial nuclear localisation is
detected (Fig. 2B,C). In this context it is worth mentioning that the
original description of the PB2 NLS [7] identified an internal
region (aa 449–495) whose deletion led to incomplete nuclear
targeting of PB2. Although this could be interpreted as result of
protein misfolding, it could also reflect the possible relevance of
amino acid at position 475. This is one of the most tightly host-
linked mutations [26] and is leucine in avian viruses and
methionine in human strains (Fig. 8B). As a whole, our results
are in agreement with the previous proposal that nuclear transport
of the viral polymerase might be a host-dependent step [17] and
further extend the implications of host-dependent PB2 interaction
with a-importin by showing that such interaction is stable and
important for virus RNA replication itself.
Materials and Methods
Biological materials
The HEK 293T cell line was obtained from J.C. de la Torre
and the HeLa cell line was acquired from ATCC. They were
cultivated as described [31]. The vaccinia virus vTF7-3 [32] was a
gift of B. Moss. Plasmids pGPB1, pGPB2, pGPA and pGNP have
been described [19]. Plasmids pGPB1TAP and pGPB2TAP, with
the TAP tag [29] fused to the C-terminus of either PB1 or PB2
were described previously [33]. The ORFs of PB1, PB2 and PA
were transferred from the pG plasmid series [19] to pcDNA3.1 to
generate plasmids pCPB1, pCPB2 and pCPA. Plasmid pCHis-
TEVPA was constructed by insertion of a 6xHis tag and the TEV
cleavage site at the N-terminus of PA (sequences available on
request). The PB2 SV mutant series was generated by insertion of
a SV40 TAg NLS sequence at the C-terminus of the protein
(sequences available on request). Plasmid pCMVNP has been
described [34]. The inserts of plasmids pT7NSCAT-RT and
pT7DNSclone23 [18] were transferred to pHH21 [35] to generate
plasmids pHHNSCAT and pHHclone23. Plasmids containing the
cDNAs of PB2 from A/Goose/Guandong/1/97 (H5N1), A/
Thailand/Kan1/04 (H5N1) and A/Vietnam/1203/04 (H5N1)
were obtained from S. Pleschka, G. Gabriel and R. Donis,
respectively. Their ORFs were transferred to pGPB2TAP to
generate plasmids pGPB2GGuaTAP, pGPB2ThTAP and
pGPB2VnTAP, respectively.
Anti-PB1 serum and anti-PB2 monoclonal antibodies have been
described [18,36,37]. Rabbit antisera specific for NP was
generated by immunisation with purified His-NP. Antibodies
Figure 6. Biological activity of recombinant RNPs with an ectopic NLS in PB2 protein. (A) Quantitative estimation of the localisation of wt
or mutant PB2 proteins was performed as indicated in Fig. 2C. (B) Cultures of HEK293T cells were co-transfected with plasmids expressing PB1, PA, NP
and either wt or mutant PB2, with or without an additional TAg NLS fused to the C-terminus of the protein. In addition, a plasmid encoding CAT gene
in negative polarity, flanked by the non-translated regions of influenza NS segment was co-transfected to provide a viral replicon. Plasmid expressing
PB2 was omitted as a negative control. At 20 hours post-transfection total cell extracts were prepared and CAT protein was determined by ELISA. The
averages and standard deviations of 3–9 independent experiments are shown.
doi:10.1371/journal.pone.0003904.g006
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specific for a5-importin, a1-importin and a5/a7-importin were
purchased to Abnova, BD Biosciences and Sigma, respectively.
Biochemical analyses
To purify PB2 associated proteins, HEK 293T cells were
infected with vTF7-3 virus at a moi of 10 pfu/cell and transfected
with plasmid pGPB2TAP, or pGPB2 as a control, using the
calcium phosphate transfection protocol [38]. After 16–20 h
incubation at 37uC, extracts were prepared and the PB2-
containing complexes were purified by the TAP approach [33].
Western-blotting and silver-staining were carried out as described
[33,39]. For immunofluorescence, HeLa cells were transfected
with pCPB2 plasmid or mutants thereof using Fugene HD reagent
(GE Healthcare) as recommended by the manufacturer and fixed
with 3,7% formaldehyde at 20 hours post-transfection. HEK293T
cells were transfected with PB2 alone or with the three subunits of
the polymerase as indicated above. At 16 hours post-transfection
they were seeded on coverslips and fixed 16 hours thereafter. The
cells were permeabilised with 0.5% Triton6100 and processed for
indirect immunofluorescence with anti-PB2 monoclonal or anti-
PB1 polyclonal antibodies as described before [40]. Images were
collected on a Leica SP5 confocal microscope (Leica Micro-
systems) and analized with the LAS AF Software (Leica
Microsystems).
Polymerase and RNP activity
To assay polymerase complex formation, HEK293T cell
cultures were co-transfected with plasmids pCPB1, pCPB2 (or
mutants thereof) and pCHisTEVPA. Total cell extracts were
analysed by 2+Ni-NTA-agarose chromatography as described [5]
and Western-blot using anti-PB2 antibodies. To determine the
RNP biological activity (transcription plus replication), HEK293T
cells were co-transfected with plasmids pCPB1, pCPB2 (or
mutants thereof), pCPA, pCMVNP and pHHNSCAT as indicat-
ed. At 20 h post-transfection, total cell extracts were prepared and
CAT protein was determined by ELISA (GE Healthcare). The
replication of recombinant RNPs was determined as follows:
HEK293T cells were infected with vaccinia vTF7-3 and
transfected with plasmids pGPB1TAP or pGPB1, pGPA, pGNP,
pT7DNS-RT clone 23 and either pCPB2 or mutants thereof
[4,18]. At 24 hours post-transfection, extracts were prepared and
the RNPs amplified in vivo were purified by binding to IgG-
Sepharose and cleavage with TEV protease [33]. The accumu-
lation of progenie RNPs was determined by Western-blot using
Figure 7. Replication capacity of recombinant RNPs with an
ectopic NLS in PB2 protein. HEK293T cells were co-transfected with
plasmids expressing either PB1-TAP or PB1, PA, NP and either wt or
mutant PB2 containing an additional TAg NLS, as well as a plasmid
encoding a viral replicon containing 248 nt [5]. Twenty four hours after
transfection, extracts were prepared and progeny RNPs were purified by
affinity chromatography on IgG-Sepharose and cleavage with TEV
protease. (A) Accumulation of purified RNPs as determined by Western-
blot using anti-NP specific antibodies. (B) Total NP present in the cell
extracts before purification. (C) Accumulation of purified RNPs as
determined by transcription in vitro using ApG (white bars) of b-globin
(black bars) as primers. The data presented are the averages and
standard deviations from three independent purification experiments.
doi:10.1371/journal.pone.0003904.g007
Figure 8. Association of human a-importin isoforms to PB2
protein from various viral strains. The PB2 proteins from either A/
Victoria/3/75 (VicTAP), A/Vietnam/1203/04 (VnTAP), A/Thailand/Kan1/04
(ThTAP) or A/Goose/Guandong/1/97 (GuaTAP) strains were TAP-tagged
and expressed by transfection into human HEK293T cells. Untagged PB2
from A/Victoria/3/75 (Vic) virus was used as a control. The PB2 protein
was purified by binding to IgG-Sepharose and elution with TEV
protease. (A) Analysis of the eluates by Western-blot using antisera
specific for a-importins a1, a5 and a5/7, as well as anti-PB2. The
position of the specific bands is indicated to the right. The star denotes
a cross-reaction band of unknown origin. (B) Comparison of the PB2
sequences of the virus strains used, at the positions identified as linked
to host-range [26]. No differences were observed among these PB2
proteins at the C-terminal NLS.
doi:10.1371/journal.pone.0003904.g008
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anti-NP sera. The activity of the purified RNPs was tested by
ApG- and b-globin mRNA-driven in vitro transcription [5,41].
Proteomic techniques
PB2 associated proteins were separated by PAGE and stained
with PAGE-blue TM (Fermentas). Proteins of interest were excissed
manually and processed as described [16]. The resulting tryptic
peptides were prepared using a standard dried droplet technique
[42] by overlaying the sample and matrix solutions, spotting an
aliquot of 0.8 ml of eluted peptides onto a 384-well Opti-TOF TM
plate (Applied Biosystems, Framingham, MA) and air drying the
samples. The same volume of matrix solution (a-cyano-4-hydroxi
cinnaminic acid in 30% acetonitrile-15% isopropanol-0.5% TFA)
was deposited.
Peptide mass fingerprinting for each protein, and subsequent
MS/MS analysis, were obtained automatically in a 4800 MALDI-
TOF/TOFTM Analyzer (Applied Biosystems, Framingham, MA),
first calibrated externally. For acquisition and peak lists generation
of each spectrum, the 4000 Series Explorer software v3.5.28193
(Applied Biosystems) was used. For protein identification, the
combined peptide mass fingerprint and MS/MS data search was
performed using GPS ExplorerTM software v3.6 (Applied
Biosystems) against the NCBInr database using MASCOT 2.1
software (Matrix Science, London, UK). Search parameters were:
carbamidomethyl cystein as fixed modification by the treatment
with iodoacetamide, oxidized methionines as variable modification
and 1 missed cleavage site allowed. Peptide and fragment mass
tolerance were set to 100 ppm and 60.8 Da, respectively. In all
protein identifications, the probability protein and peptide mowse
scores were greater than the minimum score fixed as significant.
Supporting Information
Figure S1 Expression of wt and mutant PB2 proteins. Cultures
of HEK293T cells were transfected with plasmids expressing wt
PB2 (WT), mutant PB2, with and without added TAg NLS at their
C-terminus, or mock-transfected (No PB2). Total cell extracts were
prepared and analysed by Western-blot using monoclonal
antibodies specific for PB2. An extract obtained from influenza
virus-infected cells was used as mobility marker (Flu).
Found at: doi:10.1371/journal.pone.0003904.s001 (1.66 MB TIF)
Figure S2 Intracellular localisation of wt and mutant PB2
proteins. Cultures of HEK293T cells were transfected with
plasmids expressing wt PB2, mutant PB2 or mock-transfected.
The localisation of PB2 was analysed by immunofluorescence
using monoclonal antibodies specific for PB2. Central optical
sections are presented of HEK293T cells either mock-transfected
(MOCK), transfected with wt PB2 (WT) or with each of the
mutant PB2 proteins indicated. Nuclei were stained with DAPI
(blue) and PB2 was stained with anti-PB2 monoclonal antibody
and goat anti-mouse IgG coupled with Alexa 488 (green).
Found at: doi:10.1371/journal.pone.0003904.s002 (5.40 MB TIF)
Table S1 Summary of proteomic identifications.
Found at: doi:10.1371/journal.pone.0003904.s003 (0.03 MB
DOC)
Table S2 Complete data for the proteomic analysis.
Found at: doi:10.1371/journal.pone.0003904.s004 (0.13 MB
DOC)
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